Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety.

[This corrects the article DOI: 10.1186/s40545-020-00219-1.].

Correction to: J Pharm Policy Pract (2020) 13:18

https://doi.org/10.1186/s40545-020-00219-1

Following publication of the original article [1], we notified of a mistake in the article’s title.

Correct article title:

Amid COVID-19: the importance of developing a positive reporting culture of adverse drug reaction (ADR) and medical device incident (MDI) for Global Health and public safety